Transmission of hepatitis C virus in Taiwan: Prevalence and risk factors based on a nationwide survey

Journal of Medical Virology

Volumn 59, Issue 3, 1999, Pages 290-296

  Sun, Chien An ^a   Chen, Hui Chi ^b   Lu, Chih Feng ^c   You, San Lin ^b   Mau, Yi Chiem ^d   Ho, Mei Shang ^d   Lin, Szu Heng ^c   Chen, Chien Jen ^b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c Nat Inst Prev Med   (Taiwan)

^d INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Hepatitis C virus; Iatrogenic risk factors; Interspousal concordance

Indexed keywords

ACUPUNCTURE; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; ENZYME IMMUNOASSAY; FEMALE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IATROGENIC DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; SEROPREVALENCE; TAIWAN; VIRUS TRANSMISSION;

ACUPUNCTURE THERAPY; ADULT; BLOOD TRANSFUSION; DISEASE TRANSMISSION, HORIZONTAL; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INJECTIONS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEX FACTORS; TAIWAN; TATTOOING;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0032858550     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199911)59:3<290::AID-JMV5>3.0.CO;2-R     Document Type: Article

References (38)

1. Aach RD, Stevens CE, Hollinger FB, Mosley JW, Peterson DA, Taylor PE, Johnson RG, Barbosa LH, Nemo GJ. 1991. Hepatitis C virus infection in post-transfusion hepatitis: an analysis with first- and second-generation assays. N Engl J Med 325:1325-1329.
2. Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo QL, Kuo G. 1989. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 321:1494-1500.
3. Alter MJ, Margolis HS, Krawczynski K, Judon FN, Maree A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE, Meeks EL, Beach MJ. 1992. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 327:1899-1905.
4. Bukh J, Miller RH, Purcell RH. 1995. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 15:41-63.
5. Chang TT, Liou TC, Young KC, Lin XZ, Lin CY, Shin JS, Wu HL. 1994. Intrafamilial transmission of hepatitis C virus: the important role of inapparent transmission. J Med Virol 42:91-96.
6. Chen DS, Kuo G, Sung JL, Lai MY, Sheu JC, Chen PJ, Yang PM, Hsu HM, Chang MH, Chen CJ, Hahn LC, Choo QL, Wang TH, Houghton M. 1990. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis 162:817-822.
7. Chen TZ, Wu JC, Yen FS, Sheng WY, Hwang SJ, Huo TI, Lee SD. 1995. Injection with nondisposable needles as an important route for transmission of acute community-acquired hepatitis C virus infection in Taiwan. J Med Virol 46:247-251.
8. Chomzynski P, Sacchi N. 1987. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 62:156-159.
9. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362,
10. Cuthbert JA. 1994. Hepatitis C: progress and problems. Clin Microbiol Rev 7:505-532.
11. Dienstag J. 1997. Sexual and perinatal transmission of hepatitis C. Hepatology 26(suppl 1):66S-70S.
12. Donahue JG, Nelson KE, Muñoz A, Vlahov D, Rennie LL, Taylor EL, Saah AJ, Cohn S, Odaka NJ, Farzadegan H. 1991. Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland. Am J Epidemiol 134:1206-1211.
13. Donahue JG, Muñoz A, Ness PM, Brown DE, Yawn DH, McAllister HA, Reitz BA, Nelson KE. 1992. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 327:369-373.
14. Esteban JI, González A, Hernández JM, Viladomiu L, Sánchez C, López-Talavera JC, Lucea D, Martin-Vega C, Vidal X, Esteban R, Guardia J. 1990. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 323:1107-1112.
15. Esteban JI, Cómez J, Martell M, Cabot B, Quer J, Camps J, Gonzalez A, Otero T, Moya A, Esteban R, Guardia J. 1996. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 334:555-560.
16. Kara T, Setoguchi Y, Kajihara S, Yamamoto K, Sakai T, Inoue T, Kenichi O, Mizokami M. 1996. Phylogenetic tree-based epidemiological analysis of hepatitis C virus transmission in a region of Japan with a high prevalence of infection. J Gastroenterol Hepatol 11:641-645.
17. Ho MS, Yang CS, Chen PJ, Mau CY. 1994. Intrafamilial transmission of hepatitis C virus. J Clin Microbiol 32:2824-2826.
18. Ho MS, Hsu CP, Yuh Y, King CC, Tsai JF, Mau YC, Hsu LC, Chao WH. 1997. High rate of hepatitis C virus infection in an isolated community: persistent hyperendemicity or period-related phenomena? J Med Virol 52:307-376.
19. Jenny-Avital ER. 1998. Hepatitis C. Curr Opin Infect Dis 11:293-299.
20. Kao JH, Chen PJ, Yang PM, Lai MY, Sheu JC, Wang TH, Chen DS. 1992. Intrafamilial transmission of hepatitis C virus: the important role of infections between spouses. J Infect Dis 166:900-903.
21. Kao JH, Hwang YT, Chen PJ, Yang PM, Lai MY, Wang TH, Chen DS. 1996. Transmission of hepatitis C virus between spouses: the important role of exposure duration. Am J Gastroenterol 91:2087-2090.
22. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH, Alter HJ. 1990. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12:671-675.
23. Lee SD, Chan CY, Wang YJ, Wu JC, Lai KH, Tsai YT, Lo KJ. 1991a. Seroepidemiology of hepatitis C virus infection in Taiwan. Hepatology 13:830-833.
24. Lee SD, Hwang SJ, Lu RH, Lai KH, Tsai YT, Lo KJ. 1991b. Antibodies to hepatitis C virus in prospectively followed patients with post-transfusion hepatitis. J Infect Dis 163:1354-1357.
25. Lu SN, Chue PY, Chen HC, Wu MH, Chen IL, Huang JF, Wang JH, Peng CF, Shih CH, You SL, Lu CF, Chen CJ, Chang WY. 1997. Different viral aetiology of hepatocellular carcinoma between two hepatitis B and C endemic townships in Taiwan. J Gastroenterol Hepatol 12:547-550.
26. MacDonald M, Crofts N, Kaldor J. 1996. Transmission of hepatitis C virus: rates, routes, and cofactors. Epidemiol Rev 18:137-148.
27. Noguchi S, Sata M, Suzuki H, Mizokami M, Tanikawa K. 1997. Routes of transmission of hepatitis C virus in an endemic rural area of Japan. Scand J Infect Dis 29:23-28.
28. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Tanaka, Miyakawa Y, Mayumi M. 1992. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious source. J Gen Virol 73:673-679.
29. Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, Pellet C, Stuyver L, Duval J, Dhumeaux D. 1995. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 171:1607-1610.
30. Rice PS, Smith DB, Simmonds P, Holmes E. 1993. Heterosexual transmission of hepatitis C virus. Lancet 342:1052-1053.
31. Sharara AI, Hunt CM, Hamilton JD. 1996. Hepatitis C, Ann Intern Med 125:658-668.
32. Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, Yap PL, Kolberg J, Urdea MS. 1993. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74:2391-2399.
33. Thomas DL, Vlahov D, Solomon L, Cohn S, Taylor E, Garfein R, Nelson KE. 1995. Correlates of hepatitis C virus infections among injection drug users. Medicine 74:212-220.
34. van den Hoek JAR, van Haastrecht HJA, Goudsmit J, de Wolf F, Coutinho RA. 1990. Prevalence, incidence, and risk factors of hepatitis C virus infections among injection drug users in Amsterdam. J Infect Dis 162:823-826.
35. Wang JT, Wang TH, Lin JT, Lee CZ, Sheu JC, Chen DS. 1995. Effect of hepatitis C antibody screening in blood donors on post-transfusion hepatitis in Taiwan. J Gastroenterol Hepatol 10:454-458.
36. Wang YJ, Lee SD, Hwang SJ, Chan CY, Chow MP, Lai ST, Lo KJ. 1994. Incidence of post-transfusion hepatitis before and after screening for hepatitis C virus antibody. Vox Sang 67:187-190.
37. Watanabe M, Ohkoshi S, Tawaraya H, Miyajima T, Shimotohno K, Kamimura T, Asakura H. 1994. Hepatitis C viral markers in patients who received blood that was positive for hepatitis C virus core antibody, with genetic evidence of hepatitis C virus transmission. Transfusion 34:125-129.
38. Wu JS, Lu CF, Liu WT, Lin SY. 1991. Prevalence of antibodies to hepatitis C virus (anti-HCV) in different populations in Taiwan. Chin J Microbiol Immunol 24:55-60.